These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19646743)

  • 21. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
    Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
    J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.
    Vida M; Serrano A; Romero-Cuevas M; Pavón FJ; González-Rodriguez A; Gavito AL; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
    Liver Int; 2013 Aug; 33(7):1019-28. PubMed ID: 23534555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation.
    Dai L; Feng Z; Zha R; Cheng K; Wen X; Sun H; Yuan H
    J Chem Inf Model; 2020 Mar; 60(3):1717-1727. PubMed ID: 32027126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
    Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
    Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
    Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
    J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
    Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice.
    Leuenberger N; Pradervand S; Wahli W
    J Clin Invest; 2009 Oct; 119(10):3138-48. PubMed ID: 19729835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idebenone and coenzyme Q
    Tiefenbach J; Magomedova L; Liu J; Reunov AA; Tsai R; Eappen NS; Jockusch RA; Nislow C; Cummins CL; Krause HM
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30171034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
    van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
    J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARα, PPARγ and SREBP-1 pathways mediated waterborne iron (Fe)-induced reduction in hepatic lipid deposition of javelin goby Synechogobius hasta.
    Chen GH; Luo Z; Chen F; Shi X; Song YF; You WJ; Liu X
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jul; 197():8-18. PubMed ID: 28411055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.
    Sarkar J; Qi C; Guo D; Ahmed MR; Jia Y; Usuda N; Viswakarma N; Rao MS; Reddy JK
    Gene Expr; 2007; 13(4-5):255-69. PubMed ID: 17605299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.
    McIntosh AL; Atshaves BP; Hostetler HA; Huang H; Davis J; Lyuksyutova OI; Landrock D; Kier AB; Schroeder F
    Arch Biochem Biophys; 2009 May; 485(2):160-73. PubMed ID: 19285478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.